Literature DB >> 9990613

Successful radiofrequency ablation of an accessory pathway during pregnancy.

A Domínguez1, P Iturralde, A G Hermosillo, L Colin, S Kershenovich, L M Garrido.   

Abstract

The preexcitation syndrome is a rare entity during pregnancy. We present a 20-week pregnant patient with Wolff-Parkinson-White syndrome and recurrent episodes of tachycardia with hemodynamic compromise refractory to medical treatment that required electrical cardioversion several times. Due to the poor evolution we performed a successful radiofrequency ablation of a right posteroseptal accessory pathway using 70 seconds of total fluoroscopy time without complications. We consider this is an alternative and safer treatment in those cases in which the tachyarrhythmias compromise the hemodynamic state during pregnancy.

Entities:  

Mesh:

Year:  1999        PMID: 9990613     DOI: 10.1111/j.1540-8159.1999.tb00312.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  5 in total

1.  Successful radiofrequency catheter ablation of left lateral accessory pathway using transseptal approach during pregnancy.

Authors:  Yousuf Kanjwal; Daniel Kosinski; Mohamed Kanj; William Thomas; Blair Grubb
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

2.  Cardiac arrhythmias during pregnancy.

Authors:  Thomas Adam Burkart; Jamie Beth Conti
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-10

Review 3.  Device based treatment of heart failure.

Authors:  A Y Patwala; D J Wright
Journal:  Postgrad Med J       Date:  2005-05       Impact factor: 2.401

Review 4.  [Cardiac arrhythmias in the pregnant woman and the fetus].

Authors:  H J Trappe; M Tchirikov
Journal:  Internist (Berl)       Date:  2008-07       Impact factor: 0.743

Review 5.  Arrhythmias in the pregnant patient: current concepts in evaluation and management.

Authors:  Jordana Kron; Jamie B Conti
Journal:  J Interv Card Electrophysiol       Date:  2007-08-09       Impact factor: 1.900

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.